We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more
Menu Search : Media

You are here:

  1. Media
  • Home
  • About Roche
  • Therapy Areas
  • Patient Support Program
  • Media
  • Careers
  • Contact Us

Media

 

 

 

Press Releases 

 

Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

Roche Pharma India Launches Patient Support App To Help Patients Seamlessly Navigate Their Care Journey

 

 

GATE

Roche expands its Global Analytics and Technology Center of Excellence

 

 

Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.

Fighting HER2 + Breast Cancer with innovation and hope

View more

Roche in the news

 

Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.

Roche's Evrysdi (Risdiplam) - the first and only oral treatment for adults and children two months or older suffering from Spinal Muscular Atrophy (SMA) now available in India.

 

 

Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

Roche’s Antibody Cocktail (Casirivimab and Imdevimab) is now available in India, Cipla to market it pan-India

 

 

Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19

Roche receives Emergency Use Authorisation in India for its investigational Antibody Cocktail (Casirivimab and Imdevimab) used in the treatment of Covid-19

View more

In the Spotlight

 

Mr. André Hoffmann and Dr. Jörg Duschmalé in conversation with Fortune India magazine!

Mr. André Hoffmann and Dr. Jörg Duschmalé in conversation with Fortune India magazine!

 

 

Phesgo

Medical experts view the SEC recommendation for Tecentriq for metastatic urothelial cancer as a promising development for cancer patients in the country.

 

 

Pink Project

PINK Project: Fostering early detection to reduce breast cancer burden in the society.

View more

 

 

Media Enquiries

For media enquiries, please contact:

Email: [email protected]

Share
  • Share via email
  • Share on Facebook
  • Share on Twitter
  • Share on LinkedIn
  • Share on Google+
  • Share on Xing
Close
  • © 2023
  • 06 January, 2023
  • Careers
  • Contact
  • Legal Statement
  • Privacy Policy
  • Cookie Preferences.

Disclaimer to be added as a part of Privacy Policy : This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin. This website is neither intended nor designed to record or report adverse event information. If you have a suspected side effect or problem to report regarding one of our products, visit us at https://www.rocheindia.com/en/contact.html OR please call the Roche India Safety Unit on +91-98201 63752 or E-mail us at [email protected]